Zobrazeno 1 - 10
of 39
pro vyhledávání: '"William T. Purcell"'
Autor:
Noah Kastelowitz, Megan D. Marsh, Martin McCarter, Robert A. Meguid, Narine Wandrey Bhardwaj, John D. Mitchell, Michael J. Weyant, Christopher Scott, Tracey Schefter, Priscilla Stumpf, Stephen Leong, Wells Messersmith, Christopher Lieu, Alexis D. Leal, S. Lindsey Davis, William T. Purcell, Madeleine Kane, Sachin Wani, Raj Shah, Hazem Hammad, Steven Edmundowicz, Karyn A. Goodman
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Introduction: The impact of radiation prescription dose on postoperative complications during standard of care trimodality therapy for operable stage II-III esophageal and gastroesophageal junction cancers has not been established.Methods: We retrosp
Externí odkaz:
https://doaj.org/article/0a88c470e0e044b4bc9a473147e87469
Autor:
Tejas Patil, Jose M. Pacheco, Anastasios Dimou, William T. Purcell, Candice Rossi, Paul A. Bunn, Robert C. Doebele, D. Ross Camidge, Lisa Ferrigno
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Osimertinib is a 3rd-generation tyrosine kinase inhibitor (TKI) that blocks the epidermal growth factor receptor (EGFR) in non-small lung cancer (NSCLC) and has dramatically improved outcomes for patients with EGFR mutations. While gastro
Externí odkaz:
https://doaj.org/article/8610aea244974d7f924540b02b3e2e41
Autor:
Robert C. Doebele, Alice T. Shaw, Richard B. Lanman, Kurtis D. Davies, Dara L. Aisner, William T. Purcell, Saiama N. Waqar, Joseph Diaz, Christine E. Lee, Anh T. Le, Victoria M. Raymond, Ben M. Chue, Benjamin Levy, Kimberly C. Banks, Collin M. Blakely, Caroline E. McCoach
Supplementary Figures 1,2, 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71f38d61c5fa2e8747122d6aec6577ff
https://doi.org/10.1158/1078-0432.22464351
https://doi.org/10.1158/1078-0432.22464351
Autor:
Robert C. Doebele, Alice T. Shaw, Richard B. Lanman, Kurtis D. Davies, Dara L. Aisner, William T. Purcell, Saiama N. Waqar, Joseph Diaz, Christine E. Lee, Anh T. Le, Victoria M. Raymond, Ben M. Chue, Benjamin Levy, Kimberly C. Banks, Collin M. Blakely, Caroline E. McCoach
Cohort 2 breakpoint table
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ea762d7d46728f0e6f4c9546185251b
https://doi.org/10.1158/1078-0432.22464348.v1
https://doi.org/10.1158/1078-0432.22464348.v1
Autor:
Robert C. Doebele, Alice T. Shaw, Richard B. Lanman, Kurtis D. Davies, Dara L. Aisner, William T. Purcell, Saiama N. Waqar, Joseph Diaz, Christine E. Lee, Anh T. Le, Victoria M. Raymond, Ben M. Chue, Benjamin Levy, Kimberly C. Banks, Collin M. Blakely, Caroline E. McCoach
Purpose: Patients with advanced non–small cell lung cancer (NSCLC) whose tumors harbor anaplastic lymphoma kinase (ALK) gene fusions benefit from treatment with ALK inhibitors (ALKi). Analysis of cell-free circulating tumor DNA (cfDNA) may provide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1851d73c978a019041697ca6c228eeb5
https://doi.org/10.1158/1078-0432.c.6525681.v1
https://doi.org/10.1158/1078-0432.c.6525681.v1
Autor:
Lisa J. Wingrove, Megan D. Marsh, Supriya K. Jain, Laura Melton, Karyn A. Goodman, Tracey E. Schefter, S. Lindsey Davis, William T. Purcell, Michelle Bunch, Lindel C. Dewberry, Martin D. McCarter, Ashley E. Glode, Stephen Leong
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:QIM19-130
Background: At our institution, the standard treatment recommendation for esophageal cancer patients with stage IB–IIIB disease is for neoadjuvant chemoradiation per the CROSS regimen prior to surgery. This regimen can be difficult for patients to
Autor:
William T. Purcell, Lisa J. Wingrove, Megan D. Marsh, Lindel C. Dewberry, Tracey E. Schefter, Ashley E. Glode, Martin D. McCarter, Stephen Leong
Publikováno v:
Journal of Surgical Research. 235:66-72
Background Locally advanced esophageal cancer is often treated with neoadjuvant therapy followed by surgery. Many patients present with or experience clinical deconditioning during neoadjuvant therapy. Prehabilitation programs in other areas of surge
Autor:
Christopher H. Lieu, Megan D. Marsh, Karyn A. Goodman, William T. Purcell, Noah Kastelowitz, Alexis D. Leal, Steven A. Edmundowicz, Tracey E. Schefter, Priscilla K. Stumpf, Martin D. McCarter, Raj J. Shah, S. Lindsey Davis, Christopher D. Scott, Sachin Wani, Hazem T. Hammad, Madeleine A. Kane, Narine Wandrey Bhardwaj, Robert A. Meguid, Michael J. Weyant, Stephen Leong, Wells A. Messersmith, John D. Mitchell
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
Introduction: The impact of radiation prescription dose on postoperative complications during standard of care trimodality therapy for operable stage II-III esophageal and gastroesophageal junction cancers has not been established.Methods: We retrosp
Autor:
Sarah Lindsey Davis, Swati G. Patel, Amy Walde, William T. Purcell, Patrick J. Blatchford, Rebekah Anders, Megan D. Marsh, Cheryl Meguid, Christopher H. Lieu, Steven A. Ahrendt, Elisa H. Birnbaum, Gurprataap S. Sandhu, Stephen Leong, Wells A. Messersmith, Karyn A. Goodman, Ana Gleisner, Richard D. Schulick, Jon D. Vogel, Gentry Teng King, Tracey E. Schefter, Reed Weiss, Matthew A. Brown, Alexis D. Leal, Michelle L. Cowan, Marco Del Chiaro, Whitney Herter, Martin D. McCarter
Publikováno v:
Colorectal Cancer. 9
Background: We examined characteristics of early-onset colorectal cancer (CRC) patients to identified factors, which may lead to earlier diagnosis. Materials & methods: This is a retrospective study with inclusion criteria: CRC diagnosed between 2012
Autor:
D. Ross Camidge, Anastasios Dimou, Lisa Ferrigno, Robert C. Doebele, Candice Rossi, Paul A. Bunn, Jose M. Pacheco, Tejas Patil, William T. Purcell
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
Background: Osimertinib is a 3rd-generation tyrosine kinase inhibitor (TKI) that blocks the epidermal growth factor receptor (EGFR) in non-small lung cancer (NSCLC) and has dramatically improved outcomes for patients with EGFR mutations. While gastro